InsiderClue
Insiders · Profile

Lazarus Alon

Director at Werewolf Therapeutics · Director at Keros Therapeutics. Filing since 13 Apr 2020. CIK 0001808244

HOWL Werewolf Therapeutics, Inc. Director · 1 trade KROS Keros Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
HOWL Werewolf Therapeutics, Inc.
4 May 2021
Director
Bought
400,000
$6.40M
24.3%
KROS Keros Therapeutics, Inc.
13 Apr 2020
Director
Bought
120,000
$1.92M
6.3%
2 decisions on file.